Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Baxter International Inc (BAX)

Baxter International Inc (BAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Baxter International Earnings Preview: What to Expect

With a market cap of $9.7 billion, Baxter International Inc. (BAX) is a global healthcare company that provides essential medical products and therapies used in hospitals, clinics, and home care settings. The Deerfield, Illinois-based company’s portfolio includes IV solutions, infusion systems, surgical care products, and dialysis-related offerings, positioning it as a critical supplier in acute and chronic care.

The company is expected to unveil its fiscal Q1 2026 results before the market opens on Thursday, Apr. 30. Ahead of the event, analysts forecast BAX to post an adjusted EPS of $0.31, a decline of 43.6% from $0.55 in the same...

Fundamentals

See More
  • Market Capitalization, $K 9,659,093
  • Shares Outstanding, K 516,253
  • Annual Sales, $ 11,244 M
  • Annual Income, $ -957,000 K
  • EBIT $ 177 M
  • EBITDA $ 1,933 M
  • 60-Month Beta 0.62
  • Price/Sales 0.83
  • Price/Cash Flow 3.19
  • Price/Book 1.53

Options Overview Details

View History
  • Implied Volatility 57.79% (+0.60%)
  • Historical Volatility 42.40%
  • IV Percentile 93%
  • IV Rank 31.47%
  • IV High 129.94% on 11/04/25
  • IV Low 24.66% on 06/24/25
  • Expected Move (DTE 5) 0.47 (2.50%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 4,148
  • Volume Avg (30-Day) 3,920
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 106,130
  • Open Int (30-Day) 118,798
  • Expected Range 18.24 to 19.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.31
  • Number of Estimates 8
  • High Estimate $0.33
  • Low Estimate $0.29
  • Prior Year $0.55
  • Growth Rate Est. (year over year) -43.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.73 +18.94%
on 03/30/26
19.19 -2.50%
on 04/17/26
+1.09 (+6.19%)
since 03/17/26
3-Month
15.73 +18.94%
on 03/30/26
22.41 -16.51%
on 02/11/26
-1.40 (-6.96%)
since 01/16/26
52-Week
15.73 +18.94%
on 03/30/26
32.68 -42.75%
on 05/12/25
-10.18 (-35.24%)
since 04/17/25

Most Recent Stories

More News
Baxter International Earnings Preview: What to Expect

Baxter International is set to announce its first-quarter results this month, with analysts predicting a single-digit decline in the company's earnings.

XLV : 148.80 (+1.49%)
$SPX : 7,126.06 (+1.20%)
BAX : 18.71 (+3.14%)
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

RGEN : 131.21 (+3.24%)
BAX : 18.71 (+3.14%)
CRL : 183.88 (+3.92%)
NVST : 27.84 (+3.34%)
SGRY : 14.00 (+4.24%)
3 Value Stocks We Find Risky

3 Value Stocks We Find Risky

MCW : 7.01 (+0.14%)
BAX : 18.71 (+3.14%)
BL : 31.51 (-3.67%)
Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026

Highlights include the AAT XR, the next-generation version of the Allen Advance Table designed to support surgical teams across a range of spine procedures, and...

BAX : 18.71 (+3.14%)
Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its first-quarter 2026 financial results on Thursday, April 30, 2026 at 7:30 a.m. Central...

BAX : 18.71 (+3.14%)
2 Oversold Stocks Set for a Comeback and 1 We Brush Off

2 Oversold Stocks Set for a Comeback and 1 We Brush Off

AXON : 402.85 (+2.49%)
BAX : 18.71 (+3.14%)
KBR : 36.42 (-0.74%)
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings

New system offers a standardized and simplified alternative to traditional handwritten line labeling that supports safer medication administration Solution...

BAX : 18.71 (+3.14%)
3 Reasons to Avoid BAX and 1 Stock to Buy Instead

3 Reasons to Avoid BAX and 1 Stock to Buy Instead

BAX : 18.71 (+3.14%)
Baxter to Host Annual Meeting of Stockholders in Virtual Format

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday, May 5, 2026 at 9 a.m., Central Time,...

BAX : 18.71 (+3.14%)
Baxter to Host Annual Meeting of Stockholders in Virtual Format

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday, May 5, 2026 at 9 a.m., Central Time,...

BAX : 18.71 (+3.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery,...

See More

Key Turning Points

3rd Resistance Point 20.12
2nd Resistance Point 19.66
1st Resistance Point 19.18
Last Price 18.71
1st Support Level 18.24
2nd Support Level 17.78
3rd Support Level 17.30

See More

52-Week High 32.68
Fibonacci 61.8% 26.21
Fibonacci 50% 24.20
Fibonacci 38.2% 22.20
Last Price 18.71
52-Week Low 15.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.